Production and evaluation of virus-like particles displaying immunogenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV)

International Journal of Molecular Sciences

Volumn 16, Issue 4, 2015, Pages 8382-8396

  Murthy, Ambika Mosale Venkatesh ^a   Ni, Yanyan ^b   Meng, Xiangjin ^b   Zhang, Chenming ^a  

^a Virginia Polytechnic Institute and State University   (United States)

^b CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

Inclusion bodies; Porcine reproductive and respiratory syndrome virus; PRRSV; Vaccine; VLP

Indexed keywords

EPITOPE; HEPATITIS B CORE ANTIGEN; VIRUS LIKE PARTICLE VACCINE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANION EXCHANGE CHROMATOGRAPHY; ARTERIVIRUS; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNOGENICITY; LIMULUS LYSATE TEST; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY; VIRUS EXPRESSION; VIRUS INCLUSION; VIRUS INHIBITION; VIRUS LIKE AGENT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL LINE; CHLOROCEBUS AETHIOPS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PIG; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PROTEIN REFOLDING; SOLUBILITY; VIROLOGY;

HEPATITIS B VIRUS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; EPITOPES; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; PROTEIN REFOLDING; SOLUBILITY; SWINE; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84927919333     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16048382     Document Type: Article

References (51)

1. Keffaber, K. Reproductive failure of unknown etiology. Am. Assoc. Swine Pract. Newslett. 1989, 1, 2-10.
2. Cho, J.G.; Dee, S.A. Porcine reproductive and respiratory syndrome virus. Theriogenology 2006, 66, 655-662.
3. Meng, X.J.; Paul, P.S.; Halbur, P.G.; Lum, M.A. Characterization of a high-virulence US isolate of porcine reproductive and respiratory syndrome virus in a continuous cell line, ATCC CRL11171. J. Vet. Diagn. Investig. 1996, 8, 374-381.
4. Gonin, P.; Pirzadeh, B.; Gagnon, C.A.; Dea, S. Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein. J. Vet. Diagn. Investig. 1999, 11, 20-26.
5. Weiland, E.; Wieczorek-Krohmer, M.; Kohl, D.; Conzelmann, K.K.; Weiland, F. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet. Microbiol. 1999, 66, 171-186.
6. Plagemann, P.G. The primary GP5 neutralization epitope of north american isolates of porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2004, 102, 263-275.
7. Vashisht, K.; Goldberg, T.L.; Husmann, R.J.; Schnitzlein, W.; Zuckermann, F.A. Identification of immunodominant t-cell epitopes present in glycoprotein 5 of the north american genotype of porcine reproductive and respiratory syndrome virus. Vaccine 2008, 26, 4747-4753.
8. Zuckermann, F.A.; Garcia, E.A.; Luque, I.D.; Christopher-Hennings, J.; Doster, A.; Brito, M.; Osorio, F. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet. Microbiol. 2007, 123, 69-85.
9. Botner, A.; Strandbygaard, B.; Sorensen, K.J.; Have, P.; Madsen, K.G.; Madsen, E.S.; Alexandersen, S. Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet. Record 1997, 141, 497-499.
10. Ludwig, C.; Wagner, R. Virus-like particles-universal molecular toolboxes. Curr. Opin. Biotechnol. 2007, 18, 537-545.
11. Bachmann, M.F.; Jennings, G.T. Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 2010, 10, 787-796.
12. Aguilar, J.C.; Rodriguez, E.G. Vaccine adjuvants revisited. Vaccine 2007, 25, 3752-3762.
13. Milich, D.R.; Hughes, J.; Jones, J.; Sallberg, M.; Phillips, T.R. Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate. Vaccine 2001, 20, 771-788.
14. De Filette, M.; Ramne, A.; Birkett, A.; Lycke, N.; Lowenadler, B.; Min Jou, W.; Saelens, X.; Fiers, W. The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. Vaccine 2006, 24, 544-551.
15. Wang, W.C.X.; Xue, C.; Du, Y.; Lv, L.; Liu, Q.; Li, X.; Ma, Y.; Shen, H.; Cao, Y. Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein. Vaccine 2012, 30, 7072-7077.
16. Nam, H.M.; Chae, K.S.; Song, Y.J.; Lee, N.H.; Lee, J.B.; Park, S.Y.; Song, C.S.; Seo, K.H.; Kang, S.M.; Kim, M.C.; et al. Immune responses in mice vaccinated with virus-like particles composed of the GP5 and m proteins of porcine reproductive and respiratory syndrome virus. Arch. Virol. 2013, 158, 1275-1285.
17. Hu, J.; Ni, Y.; Meng, X.J.; Zhang, C. Expression and purification of a chimeric protein consisting of the ectodomains of m and GP5 proteins of porcine reproductive and respiratory syndrome virus (PRRSV). J. Chromatogr. B 2012, 911, 43-48.
18. Bottcher, B.; Wynne, S.A.; Crowther, R.A. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 1997, 386, 88-91.
19. Livingston, B.D.; Newman, M.; Crimi, C.; McKinney, D.; Chesnut, R.; Sette, A. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 2001, 19, 4652-4660.
20. Koho, T.; Mantyla, T.; Laurinmaki, P.; Huhti, L.; Butcher, S.J.; Vesikari, T.; Kulomaa, M.S.; Hytonen, V.P. Purification of norovirus-like particles (VLPs) by ion exchange chromatography. J. Virol. Methods 2012, 181, 6-11.
21. Kimman, T.G.; Cornelissen, L.A.; Moormann, R.J.; Rebel, J.M.; Stockhofe-Zurwieden, N. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine 2009, 27, 3704-3718.
22. Mengeling, W.L.; Lager, K.M.; Vorwald, A.C.; Clouser, D.F. Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome. Vet. Microbiol. 2003, 93, 25-38.
23. Mengeling, W.L.; Lager, K.M.; Vorwald, A.C.; Koehler, K.J. Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus. Vet. Microbiol. 2003, 93, 13-24.
24. Barfoed, A.M.; Blixenkrone-Moller, M.; Jensen, M.H.; Botner, A.; Kamstrup, S. DNA vaccination of pigs with open reading frame 1-7 of PRRS virus. Vaccine 2004, 22, 3628-3641.
25. Rompato, G.; Ling, E.; Chen, Z.; van Kruiningen, H.; Garmendia, A.E. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine. Vet. Immunol. Immunopathol. 2006, 109, 151-160.
26. Bastos, R.G.; Dellagostin, O.A.; Barletta, R.G.; Doster, A.R.; Nelson, E.; Zuckermann, F.; Osorio, F.A. Immune response of pigs inoculated with mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 2004, 22, 467-474.
27. Cai, J.; Ma, Y.; Li, J.; Yan, C.; Hu, R.; Zhang, J. Construction and characterization of a recombinant canine adenovirus expressing GP5 and m proteins of porcine reproductive and respiratory syndrome virus. J. Vet. Med. Sci. 2010, 72, 1035-1040.
28. Jiang, W.; Jiang, P.; Wang, X.; Li, Y.; Du, Y.; Wang, X. Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of prrs virus. Virus Res. 2008, 136, 50-57.
29. Zhou, J.X.; Xue, J.D.; Yu, T.; Zhang, J.B.; Liu, Y.; Jiang, N.; Li, Y.L.; Hu, R.L. Immune responses in pigs induced by recombinant canine adenovirus 2 expressing the glycoprotein 5 of porcine reproductive and respiratory syndrome virus. Vet. Res. Commun. 2010, 34, 371-380.
30. Shen, G.; Jin, N.; Ma, M.; Jin, K.; Zheng, M.; Zhuang, T.; Lu, H.; Zhu, G.; Jin, H.; Jin, M.; et al. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine il-18. Vaccine 2007, 25, 4193-4202.
31. Zheng, Q.; Chen, D.; Li, P.; Bi, Z.; Cao, R.; Zhou, B.; Chen, P. Co-expressing gp5 and m proteins under different promoters in recombinant modified vaccinia virus ankara (RMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV). Virus Genes 2007, 35, 585-595.
32. Mogler, M.A.; Vander Veen, R.L.; Erdman, M.M.; Harris, D.L. Replicon Particles Expressing PRRSV GP5 and Matrix Reduce Viremia Following Homologous and Heterologous Challenge. In Proceeding of International PRRS Symposium, 2009; p. 107. Available online: http://www.prrssymposium.org/TopMenu/Proceedings.aspx (accessed on 13 April 2015).
33. Plana Duran, J.; Climent, I.; Sarraseca, J.; Urniza, A.; Cortes, E.; Vela, C.; Casal, J.I. Baculovirus expression of proteins of porcine reproductive and respiratory syndrome virus strain olot/91. Involvement of orf3 and orf5 proteins in protection. Virus Genes 1997, 14, 19-29.
34. Cruz, J.L.; Zuniga, S.; Becares, M.; Sola, I.; Ceriani, J.E.; Juanola, S.; Plana, J.; Enjuanes, L. Vectored vaccines to protect against PRRSV. Virus Res. 2010, 154, 150-160.
35. Chen, X.; Liu, J. Generation and immunogenicity of transgenic potato expressing the GP5 protein of porcine reproductive and respiratory syndrome virus. J. Virol. Methods 2011, 173, 153-158.
36. Chia, M.Y.; Hsiao, S.H.; Chan, H.T.; Do, Y.Y.; Huang, P.L.; Chang, H.W.; Tsai, Y.C.; Lin, C.M.; Pang, V.F.; Jeng, C.R. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant. Vet. Immunol. Immunopathol. 2010, 135, 234-242.
37. Hu, J.; Ni, Y.; Dryman, B.A.; Meng, X.J.; Zhang, C. Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV). Vaccine 2012, 30, 2068-2074.
38. Charerntantanakul, W.; Platt, R.; Johnson, W.; Roof, M.; Vaughn, E.; Roth, J.A. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2006, 109, 99-115.
39. Karpenko, L.I.; Ivanisenko, V.A.; Pika, I.A.; Chikaev, N.A.; Eroshkin, A.M.; Veremeiko, T.A.; Ilyichev, A.A. Insertion of foreign epitopes in hbcag: How to make the chimeric particle assemble. Amino Acids 2000, 18, 329-337.
40. Jegerlehner, A.; Storni, T.; Lipowsky, G.; Schmid, M.; Pumpens, P.; Bachmann, M.F. Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur. J. Immunol. 2002, 32, 3305-3314.
41. Kirnbauer, R.; Booy, F.; Cheng, N.; Lowy, D.R.; Schiller, J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 1992, 89, 12180-12184.
42. Lee, D.H.; Park, J.K.; Lee, Y.N.; Song, J.M.; Kang, S.M.; Lee, J.B.; Park, S.Y.; Choi, I.S.; Song, C.S. H9n2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine 2011, 29, 4003-4007.
43. Brun, A.; Barcena, J.; Blanco, E.; Borrego, B.; Dory, D.; Escribano, J.M.; Le Gall-Recule, G.; Ortego, J.; Dixon, L.K. Current strategies for subunit and genetic viral veterinary vaccine development. Virus Res. 2011, 157, 1-12.
44. Li, B.; Xiao, S.; Wang, Y.; Xu, S.; Jiang, Y.; Chen, H.; Fang, L. Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic orf5 gene. Vaccine 2009, 27, 1957-1963.
45. Lopez, O.J.; Osorio, F.A. Role of neutralizing antibodies in prrsv protective immunity. Vet. Immunol. Immunopathol. 2004, 102, 155-163.
46. Mateu, E.; Diaz, I. The challenge of prrs immunology. Vet. J. 2008, 177, 345-351.
47. Ostrowski, M.; Galeota, J.A.; Jar, A.M.; Platt, K.B.; Osorio, F.A.; Lopez, O.J. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J. Virol. 2002, 76, 4241-4250.
48. Franke, E.D.; Hoffman, S.L.; Sacci, J.B., Jr.; Wang, R.; Charoenvit, Y.; Appella, E.; Chesnut, R.; Alexander, J.; Del Guercio, M.F.; Sette, A. Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites. Vaccine 1999, 17, 1201-1205.
49. Leng, C.L.; An, T.Q.; Chen, J.Z.; Gong, D.Q.; Peng, J.M.; Yang, Y.Q.; Wu, J.; Guo, J.J.; Li, D.Y.; Zhang, Y.; et al. Highly pathogenic porcine reproductive and respiratory syndrome virus GP5 B antigenic region is not a neutralizing antigenic region. Vet. Microbiol. 2012, 159, 273-281.
50. Li, J.; Murtaugh, M.P. Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes. Virology 2012, 433, 367-376.
51. Chen, C.; Li, J.; Bi, Y.; Yang, L.; Meng, S.; Zhou, Y.; Jia, X.; Meng, S.; Sun, L.; Liu, W. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity. Vaccine 2013, 31, 1838-1847.